Biomarin Pharmaceutical reported $15.25B in Market Capitalization for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Acadia Pharmaceuticals ACAD:US $ 3.91B 222.46M
Acceleron Pharma XLRN:US $ 7.62B 606.02M
Acorda Therapeutics ACOR:US $ 45.26M 955.08K
Agios Pharmaceuticals AGIO:US $ 3.39B 211.72M
Alexion Pharmaceuticals ALXN:US $ 33.78B 393.15M
Alnylam Pharmaceuticals ALNY:US $ 19.93B 3.36B
Amgen AMGN:US $ 140.05B 3.22B
Arena Pharmaceuticals ARNA:US $ 4.16B 41.38M
Bayer BAYN:GR 50.48B 2.53B
Biogen BIIB:US $ 52.13B 9.52B
Biomarin Pharmaceutical BMRN:US $ 15.25B 1.45B
Bluebird Bio BLUE:US $ 2.16B 132.67M
Gilead Sciences GILD:US $ 86.36B 4.99B
Gw Pharmaceuticals GWPH:US 6.44B 2.84B
Insmed INSM:US $ 3.22B 293.47M
Intercept Pharmaceuticals ICPT:US $ 663.03M 98.97M
IONIS PHARMACEUT IONS:US $ 5.62B 710.4M
Moderna Inc MRNA:US $ 94.35B 41.95B
Neurocrine Biosciences NBIX:US $ 9.2B 7.62M
Ptc Therapeutics PTCT:US $ 2.98B 347.22M
Puma Biotechnology PBYI:US $ 370.52M 20.79M
Regeneron Pharmaceuticals REGN:US $ 59.5B 8.81B
Sangamo Biosciences SGMO:US $ 1.72B 78.47M
Sanofi SNY:US 132.07B 7.67B
Sarepta Therapeutics SRPT:US $ 6.2B 282.45M
Seattle Genetics SGEN:US $ 28.65B 3.48B
Ultragenyx Pharmaceutical RARE:US $ 6.43B 1.19B
United Therapeutics UTHR:US $ 8.04B 550.55M
Vertex Pharmaceuticals VRTX:US $ 52.2B 3.42B
YTE INCY:US $ 18.5B 632.77M